N-(p-Tosyl)-GPR-pNA acetate

CAS No. 86890-95-1

N-(p-Tosyl)-GPR-pNA acetate( —— )

Catalog No. M28105 CAS No. 86890-95-1

N-(p-Tosyl)-GPR-pNA acetate is a colorimetric substrate for thrombin that can act as a measure of thrombin activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 48 In Stock
5MG 65 In Stock
10MG 92 In Stock
25MG 166 In Stock
50MG 306 In Stock
100MG 542 In Stock
200MG Get Quote In Stock
500MG 1181 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-(p-Tosyl)-GPR-pNA acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    N-(p-Tosyl)-GPR-pNA acetate is a colorimetric substrate for thrombin that can act as a measure of thrombin activity.
  • Description
    N-(p-Tosyl)-GPR-pNA acetate is a colorimetric substrate for thrombin that can act as a measure of thrombin activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    KLF5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    86890-95-1
  • Formula Weight
    662.7
  • Molecular Formula
    C26H34N8O7S.C2H4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N/A
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bialkowska AB, et, al. Identification of small-molecule inhibitors of the colorectal cancer oncogene Krüppel-like factor 5 expression by ultrahigh-throughput screening. Mol Cancer Ther. 2011 Nov; 10(11): 2043-51.
molnova catalog
related products
  • NR2E3 agonist 1

    NR2E3 agonist 1 is a small molecule photoreceptor-specific nuclear receptor (NR2E3) agonist with antitumor activity for the study of diseases caused by abnormalities in photoreceptor cell-specific receptors.

  • WRW4 TFA(878557-55-2...

    Selective antagonist of formyl peptide receptor 2 (FPR2) signaling. Inhibits WKYMVm binding to FPR2 (IC50 = 0.23 μM) and inhibits intracellular calcium release induced by WKYMVm, MMK 1, amyloid β42, and F peptide. Also inhibits FPR2-mediated signaling in human neutrophils; blocks chemotactic migration and superoxide generation by amyloid β42 peptide.

  • Polygalasaponin II

    Polygalasaponin F analog. Reference standards.